RECRUITINGOBSERVATIONAL
Risk Stratification Value of Biomarkers in Patients With Myocarditis
Risk Stratification Value of Biomarkers in Patients With Myocarditis (FORWARD): a National, Multicenter, Retrospective-prospective, Cohort Study
About This Trial
The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.
Who May Be Eligible (Plain English)
Who May Qualify:
- All patients should meet the diagnostic criteria for myocarditis
- Patients who are regularly followed up at the corresponding cardiovascular center
Who Should NOT Join This Trial:
- Age \<3 years or \>80 years
- Pregnant or lactating women
- The patient refused to sign the willing to sign a consent form and refused to participate in the study
- None of the above is consistent, but the patient cannot sign the willing to sign a consent form temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* All patients should meet the diagnostic criteria for myocarditis
* Patients who are regularly followed up at the corresponding cardiovascular center
Exclusion Criteria:
* Age \<3 years or \>80 years
* Pregnant or lactating women
* The patient refused to sign the informed consent and refused to participate in the study
* None of the above is consistent, but the patient cannot sign the informed consent temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the informed consent
Locations (1)
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China